Annual Retained Earnings
-$336.20 M
-$28.03 M-9.10%
December 31, 2023
Summary
- As of February 8, 2025, ONCY annual retained earnings is -$336.20 million, with the most recent change of -$28.03 million (-9.10%) on December 31, 2023.
- During the last 3 years, ONCY annual retained earnings has fallen by -$48.31 million (-16.78%).
- ONCY annual retained earnings is now -84992.43% below its all-time high of -$395.10 thousand, reached on December 31, 1999.
Performance
ONCY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$347.65 M
-$11.69 M-3.48%
September 30, 2024
Summary
- As of February 8, 2025, ONCY quarterly retained earnings is -$347.65 million, with the most recent change of -$11.69 million (-3.48%) on September 30, 2024.
- Over the past year, ONCY quarterly retained earnings has dropped by -$22.44 million (-6.90%).
- ONCY quarterly retained earnings is now -59715.12% below its all-time high of -$581.20 thousand, reached on March 31, 2000.
Performance
ONCY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ONCY Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.1% | -6.9% |
| 3 y3 years | -16.8% | -12.8% |
| 5 y5 years | -47.0% | -12.8% |
ONCY Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.1% | at low | -16.1% | at low |
| 5 y | 5-year | -27.4% | at low | -43.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Oncolytics Biotech Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$347.65 M(+3.5%) |
| Jun 2024 | - | -$335.95 M(+0.2%) |
| Mar 2024 | - | -$335.18 M(-0.3%) |
| Dec 2023 | -$336.20 M(+9.1%) | -$336.20 M(+3.4%) |
| Sep 2023 | - | -$325.21 M(-0.3%) |
| Jun 2023 | - | -$326.08 M(+3.9%) |
| Mar 2023 | - | -$313.98 M(+1.9%) |
| Dec 2022 | -$308.17 M(-0.1%) | -$308.17 M(+2.9%) |
| Sep 2022 | - | -$299.58 M(-4.8%) |
| Jun 2022 | - | -$314.54 M(-1.9%) |
| Mar 2022 | - | -$320.55 M(+3.9%) |
| Dec 2021 | -$308.56 M(+7.2%) | -$308.56 M(+2.1%) |
| Sep 2021 | - | -$302.36 M(-1.5%) |
| Jun 2021 | - | -$307.11 M(+3.8%) |
| Mar 2021 | - | -$295.93 M(+2.8%) |
| Dec 2020 | -$287.89 M(+9.1%) | -$287.89 M(+7.7%) |
| Sep 2020 | - | -$267.29 M(+4.0%) |
| Jun 2020 | - | -$257.02 M(+5.9%) |
| Mar 2020 | - | -$242.71 M(-8.0%) |
| Dec 2019 | -$263.81 M(+15.4%) | -$263.81 M(+7.4%) |
| Sep 2019 | - | -$245.66 M(+0.3%) |
| Jun 2019 | - | -$245.03 M(+3.4%) |
| Mar 2019 | - | -$236.98 M(+3.6%) |
| Dec 2018 | -$228.69 M(-2.3%) | -$228.69 M(-3.7%) |
| Sep 2018 | - | -$237.35 M(+3.7%) |
| Jun 2018 | - | -$228.81 M(-1.2%) |
| Mar 2018 | - | -$231.62 M(-1.1%) |
| Dec 2017 | -$234.15 M(+13.2%) | -$234.15 M(+0.5%) |
| Sep 2017 | - | -$232.91 M(+5.7%) |
| Jun 2017 | - | -$220.44 M(+4.1%) |
| Mar 2017 | - | -$211.72 M(+2.4%) |
| Dec 2016 | -$206.81 M(+8.8%) | -$206.81 M(-0.6%) |
| Sep 2016 | - | -$208.11 M(-0.4%) |
| Jun 2016 | - | -$208.91 M(+1.3%) |
| Mar 2016 | - | -$206.24 M(+8.5%) |
| Dec 2015 | -$190.02 M(-11.8%) | -$190.02 M(-2.0%) |
| Sep 2015 | - | -$193.81 M(-6.5%) |
| Jun 2015 | - | -$207.34 M(+3.7%) |
| Mar 2015 | - | -$199.97 M(-7.1%) |
| Dec 2014 | -$215.33 M(-0.9%) | -$215.33 M(-2.4%) |
| Sep 2014 | - | -$220.56 M(-2.6%) |
| Jun 2014 | - | -$226.41 M(+5.7%) |
| Mar 2014 | - | -$214.26 M(-1.4%) |
| Dec 2013 | -$217.27 M(+4.0%) | -$217.27 M(-0.6%) |
| Sep 2013 | - | -$218.65 M(+4.4%) |
| Jun 2013 | - | -$209.38 M(-0.8%) |
| Mar 2013 | - | -$211.02 M(+1.0%) |
| Dec 2012 | -$208.90 M | -$208.90 M(+2.8%) |
| Sep 2012 | - | -$203.17 M(+10.5%) |
| Jun 2012 | - | -$183.88 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -$180.46 M(+7.5%) |
| Dec 2011 | -$167.93 M(+21.0%) | -$167.93 M(+9.1%) |
| Sep 2011 | - | -$153.96 M(-2.9%) |
| Jun 2011 | - | -$158.52 M(+5.3%) |
| Mar 2011 | - | -$150.60 M(+8.5%) |
| Dec 2010 | -$138.74 M(+23.1%) | -$138.74 M(+9.1%) |
| Sep 2010 | - | -$127.17 M(+6.2%) |
| Jun 2010 | - | -$119.74 M(-1.0%) |
| Mar 2010 | - | -$120.99 M(+7.3%) |
| Dec 2009 | -$112.73 M(+35.4%) | -$112.73 M(+6.1%) |
| Sep 2009 | - | -$106.21 M(+11.4%) |
| Jun 2009 | - | -$95.36 M(+13.0%) |
| Mar 2009 | - | -$84.37 M(+1.4%) |
| Dec 2008 | -$83.24 M(-2.3%) | -$83.24 M(-9.4%) |
| Sep 2008 | - | -$91.91 M(+0.1%) |
| Jun 2008 | - | -$91.83 M(+12.4%) |
| Mar 2008 | - | -$81.73 M(-4.0%) |
| Dec 2007 | -$85.17 M(+52.7%) | -$85.17 M(+10.7%) |
| Sep 2007 | - | -$76.94 M(+12.8%) |
| Jun 2007 | - | -$68.24 M(+14.1%) |
| Mar 2007 | - | -$59.78 M(+7.2%) |
| Dec 2006 | -$55.76 M(+27.7%) | -$55.76 M(+3.6%) |
| Sep 2006 | - | -$53.84 M(+6.0%) |
| Jun 2006 | - | -$50.80 M(+10.4%) |
| Mar 2006 | - | -$45.99 M(+5.4%) |
| Dec 2005 | -$43.65 M(+38.2%) | -$43.65 M(-6.5%) |
| Sep 2005 | - | -$46.70 M(+32.2%) |
| Jun 2005 | - | -$35.32 M(+6.0%) |
| Mar 2005 | - | -$33.32 M(+5.5%) |
| Dec 2004 | -$31.58 M(+64.1%) | -$31.58 M(+17.3%) |
| Sep 2004 | - | -$26.92 M(+16.3%) |
| Jun 2004 | - | -$23.14 M(+9.6%) |
| Mar 2004 | - | -$21.12 M(+9.7%) |
| Dec 2003 | -$19.25 M(+84.6%) | -$19.25 M(+11.5%) |
| Sep 2003 | - | -$17.26 M(+8.8%) |
| Jun 2003 | - | -$15.86 M(+32.9%) |
| Mar 2003 | - | -$11.93 M(+14.5%) |
| Dec 2002 | -$10.42 M(+60.7%) | -$10.42 M(+10.4%) |
| Sep 2002 | - | -$9.44 M(+10.0%) |
| Jun 2002 | - | -$8.59 M(+17.8%) |
| Mar 2002 | - | -$7.29 M(+12.4%) |
| Dec 2001 | -$6.49 M(+132.4%) | -$6.49 M(+13.7%) |
| Sep 2001 | - | -$5.70 M(+32.5%) |
| Jun 2001 | - | -$4.30 M(+30.2%) |
| Mar 2001 | - | -$3.30 M(+18.4%) |
| Dec 2000 | -$2.79 M(+606.2%) | -$2.79 M(+14.3%) |
| Sep 2000 | - | -$2.44 M(+70.8%) |
| Jun 2000 | - | -$1.43 M(+146.0%) |
| Mar 2000 | - | -$581.20 K |
| Dec 1999 | -$395.10 K | - |
FAQ
- What is Oncolytics Biotech annual retained earnings?
- What is the all time high annual retained earnings for Oncolytics Biotech?
- What is Oncolytics Biotech annual retained earnings year-on-year change?
- What is Oncolytics Biotech quarterly retained earnings?
- What is the all time high quarterly retained earnings for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly retained earnings year-on-year change?
What is Oncolytics Biotech annual retained earnings?
The current annual retained earnings of ONCY is -$336.20 M
What is the all time high annual retained earnings for Oncolytics Biotech?
Oncolytics Biotech all-time high annual retained earnings is -$395.10 K
What is Oncolytics Biotech annual retained earnings year-on-year change?
Over the past year, ONCY annual retained earnings has changed by -$28.03 M (-9.10%)
What is Oncolytics Biotech quarterly retained earnings?
The current quarterly retained earnings of ONCY is -$347.65 M
What is the all time high quarterly retained earnings for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly retained earnings is -$581.20 K
What is Oncolytics Biotech quarterly retained earnings year-on-year change?
Over the past year, ONCY quarterly retained earnings has changed by -$22.44 M (-6.90%)